Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results

PURPOSE: Eribulin mesilate was approved for the treatment of patients with locally advanced or metastatic breast cancer (MBC), who had received at least two chemotherapeutic regimens, including anthracycline and taxane. On the other hand, the efficacy and safety information of eribulin in Korean pat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Res Treat
Main Authors: Park, Yeon Hee, Kim, Tae Yong, Im, Young-Hyuck, Lee, Keun-Seok, Park, In Hae, Sohn, Joohyuk, Lee, Soo-Hyeon, Im, Seock-Ah, Kim, Jee Hyun, Kim, Se Hyun, Lee, Soo Jung, Koh, Su-Jin, Lee, Ki Hyeong, Choi, Yoon Ji, Cho, Eun Kyung, Lee, Suee, Kang, Seok Yun, Seo, Jae Hong, Kim, Sung-Bae, Jung, Kyung Hae
Format: Artigo
Sprog:Inglês
Udgivet: Korean Cancer Association 2017
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398406/
https://ncbi.nlm.nih.gov/pubmed/27488876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.191
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker